Keyword Analysis & Research: hybrid and multicloud growth hormone

Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
hybrid and multicloud growth hormone0.310.896612836
hybrid1.670.68516686
and1.310.22252903
multicloud1.50.316816510
growth0.760.16906876
hormone1.870.78346987

Keyword Research: People who searched hybrid and multicloud growth hormone also searched

Keyword CPC PCC Volume Score
hybrid and multicloud growth hormone1.960.985811
hybrid and multicloud growth hormone+means1.90.8776096
hybrid cloud and multicloud1.911887083

Search Results related to hybrid and multicloud growth hormone on Search Engine

  • Connected health for growth hormone treatment research and …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074467/

    WEBApr 26, 2021 · Connected health for growth hormone treatment research and clinical practice: learnings from different sources of real-world evidence (RWE)—large electronically collected datasets, surveillance studies and individual patients’ cases hybrid

    hybrid

    DA: 27 PA: 82 MOZ Rank: 29

  • Targeting growth hormone function: strategies and therapeutic

    nature.com

    https://www.nature.com/articles/s41392-019-0036-y

    WEBFeb 8, 2019 · Human growth hormone (GH) is a peptide hormone that is secreted from the anterior pituitary. It has a central function of regulating postnatal growth and metabolism and exhibits pleiotropic... hybrid

    hybrid

    DA: 31 PA: 59 MOZ Rank: 69

  • Integrated Digital Health Solutions in the Management of Growth

    frontiersin.org

    https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.882192/full

    WEBJun 29, 2022 · Here, we share our perspectives and experience from over a decade of providing digital health solutions for managing growth hormone (GH) therapy in children and adolescents. These solutions represent one of the most broadly implemented digital health solutions in pediatrics. hybrid

    hybrid

    DA: 95 PA: 94 MOZ Rank: 12

  • Adherence and long-term outcomes of growth hormone therapy …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733364/

    WEBJul 31, 2019 · Results. Overall adherence was 94.5%; 97.5% after 6 months, 95.3% after 1 year, 93.7% after 2, 94.4% after 3 and 95.5% after 4 years of treatment. No differences in adherence were observed between prepubertal and pubertal groups and GHD and SGA groups. Change in height after 1 and 2 years, change in height SDS after 1 and 2 years, … hybrid

    hybrid

    DA: 85 PA: 85 MOZ Rank: 91

  • Effect of switching recombinant human growth hormone: …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873068/

    WEBDec 16, 2011 · Recombinant human GH (rhGH, somatropin) stimulates production of insulin-like growth factor (IGF-1), which increases bone growth, muscle strength, and cardiac output, and enhances expression of IGF binding proteins (IGFBP-3). 2 However, growth response to GH treatment varies, even in a relatively homogeneous group of patients … hybrid

    hybrid

    DA: 9 PA: 13 MOZ Rank: 51

  • Analysis of real-world data on growth hormone therapy adherence using …

    biomedcentral.com

    https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-020-01183-1

    WEBJul 29, 2020 · Analysis of real-world data on growth hormone therapy adherence using a connected injection device. Ekaterina Koledova, Vincenzo Tornincasa & Paula van Dommelen. BMC Medical Informatics and Decision Making 20, Article number: 176 ( 2020 ) Cite this article. 2974 Accesses. 15 Citations. Metrics. Abstract. Background. hybrid

    hybrid

    DA: 77 PA: 97 MOZ Rank: 60

  • Optimized clinical performance of growth hormone with an ... - PNAS

    pnas.org

    https://www.pnas.org/doi/10.1073/pnas.1100387108

    WEBMay 16, 2011 · Incorporation of p -acetylphenylalanine (pAcF) at distinct locations in human growth hormone (hGH) allowed site-specific conjugation with polyethylene glycol (PEG) to produce homogeneous hGH variants. A mono-PEGylated mutant hGH modified at residue 35 demonstrated favorable pharmacodynamic properties in GH-deficient rats. hybrid

    hybrid

    DA: 61 PA: 76 MOZ Rank: 78

  • Challenges and future for the delivery of growth hormone therapy

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/29289483/

    WEBToday and in the future, the fusion of biochemistry, biology and nanotechnology will provide hybrid devices using microfluidic systems. But, until new technologies for GH delivery will become available, current methods must be reinforced in conjunction with the development of better communication strategies between the health system and patients.

    DA: 12 PA: 82 MOZ Rank: 58

  • Identification, characterization, and expressions profile analysis of

    sciencedirect.com

    https://www.sciencedirect.com/science/article/pii/S088875431930059X

    WEBJan 1, 2020 · Identification, characterization, and expressions profile analysis of growth hormone receptors (GHR1 and GHR2) in Hybrid grouper (Epinephelus fuscoguttatus ♀ × Epinephelus polyphekadion ♂) - ScienceDirect.

    DA: 47 PA: 82 MOZ Rank: 27

  • Connected health for growth hormone treatment research and

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/33902570/

    WEBApr 26, 2021 · Connected health for growth hormone treatment research and clinical practice: learnings from different sources of real-world evidence (RWE)-large electronically collected datasets, surveillance studies and individual patients' cases. BMC Med Inform Decis Mak. 2021 Apr 26;21 (1):136. doi: 10.1186/s12911-021-01491-0. hybrid

    hybrid

    DA: 89 PA: 78 MOZ Rank: 52